Book Clinical Trials Conditions Treatment 
LifeCannMD
FEBRUARY 27, 2024
How Medical Marijuana Is Changing Lives with Crohn’s Disease Medical Marijuana is a great treatment option for battling Crohn’s Disease, a chronic inflammatory bowel condition that affects millions worldwide. Some clinical trials have focused on the anti-inflammatory effects of cannabis in Crohn’s disease.
Cannabis Law Report
MAY 31, 2022
The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. Food and Drug Administration (FDA) approved esketamine (a component of Ketamine and sold under the brand name Spravato) for treatment-resistant depression.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MMJ Recs
JUNE 15, 2022
Medical marijuana (MMJ) is used to treat pain from a wide variety of conditions or illnesses, including everything from chronic back pain to arthritis. There are many treatments that can be utilized along with MMJ products to alleviate pain, such as medications, physical therapy, and massage. Pain Treatment Specialists.
Cannabis Law Report
MAY 29, 2022
Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. Celebrated author Michael Pollan has published two bestselling books on the topic: How to Change Your Mind and This is Your Mind on Plants. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8]
Otherside Farms
APRIL 30, 2019
It was recognized by the emperor at the time, Shen-Nung, as a treatment for over 100 different ailments. This was the year that the Endocannabinoid system was officially discovered, named, and put in the books. This treatment of CBD oil was found to be more effective than traditional medications for anxiety. Chronic pain.
Project CBD
OCTOBER 26, 2023
As part of the approval process for all markets, they have conducted critical Phase 2 studies on various conditions, including cancer. They conducted a double-blind, placebo-controlled phase 2 clinical trial using Sativex® in conjunction with temozolomide to treat recurrent glioblastoma multiforme (GBM).
Project CBD
MAY 3, 2023
CannMed: For what conditions do you think CBG has the most promise? Psoriasis is a well-known condition where people get not only joint pain but they also get these thick red patches and scales on their skin. It can be a very difficult condition. But we may be on the cusp of having those trials, which would be very exciting.
Expert insights. Personalized for you.
59 
Let's personalize your content